Estimaciones de analistas de Wall Street para Agilon Health, Inc. (AGL): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 8 |
| Mantener | 15 |
| Venta | 2 |
| Venta fuerte | 0 |
| Analistas totales | 25 |
| Calificación media (1-5) | 0.24 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-03 | $-1.22 | ||
| 2026-08-05 | $1.04 | $0.14 | +622.2% |
| 2026-05-06 | $1.80 | $1.13 | +59.3% |
| 2026-02-25 | $-11.50 | $-6.75 | -70.4% |
| 2025-11-04 | $-6.75 | $-3.73 | -80.7% |
| 2025-08-05 | $-6.25 | $-2.75 | -127.3% |
| 2025-05-06 | $0.73 | $-0.07 | +1082.4% |
| 2025-02-25 | $-6.50 | $-0.18 | -3511.1% |
Ratios de valoración
| Precio / Valor contable | 6.66 |
| EV / EBITDA | -5.99 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Ingresos | $794.4M | $1.22B | $1.52B | $2.39B | $4.32B | $6.06B | $5.93B |
| Coste de Ventas | $765.9M | $1.12B | $1.46B | $2.28B | $4.25B | $6.06B | $6.12B |
| Beneficio Bruto | $28.5M | $94.2M | $65.7M | $111.4M | $69.7M | $4.8M | -$188.6M |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $122.8M | $137.3M | $427.5M | $207.8M | $285.8M | $268.9M | $238.5M |
| Gastos Operativos | $135.1M | $150.8M | $438.0M | $216.7M | $301.8M | $297.0M | $232.5M |
| Beneficio Operativo | -$106.6M | -$56.7M | -$372.2M | -$105.4M | -$232.1M | -$292.1M | -$421.1M |
| EBITDA | -$64.2M | -$40.1M | -$362.2M | -$72.4M | -$167.6M | -$218.2M | -$368.9M |
| Gastos por Intereses | $9.1M | $8.1M | $6.1M | $4.5M | $6.7M | $6.2M | $6.6M |
| Beneficio Antes de Impuestos | -$114.7M | -$62.3M | -$383.0M | -$90.7M | -$194.5M | -$248.8M | -$404.1M |
| Impuestos | -$232000 | $865000 | $886000 | $1.6M | $791000 | $1.5M | $1.3M |
| Beneficio Neto | -$282.6M | -$60.1M | -$406.5M | -$106.6M | -$262.6M | -$260.2M | -$405.3M |
| BPA | $-18.50 | $-4.00 | $-27.25 | $-6.50 | $-16.00 | $-15.75 | $-24.50 |
| BPA Diluido | $-18.50 | $-4.00 | $-27.25 | $-6.50 | $-16.00 | $-15.75 | $-24.50 |
| Acciones en Circulación (Diluidas) | $15.4M | $15.4M | $14.9M | $16.3M | $16.4M | $16.4M | $16.6M |
Precio
| Precio | $89.66 |
| Capitalización | $1.5B |
| Bolsa | NYSE |
| País | US |
Empresas relacionadas: ANNX · DBVT · DH · EHAB · ENGN · LRMR · MCTA
Explorar sector: Healthcare · Medical - Care Facilities
Más secciones de AGL: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones